Pediatric Precision Medicine and Experimental Therapeutics

Pediatric Precision Medicine and Experimental Therapeutics

This group belongs to the UMR 1015 "Tumour Immunology and anti-cancer immunotherapy".

The aim of our group is to develop new innovative therapies for children with advanced cancers through our clinical precision cancer medicine trials, with one group focusing on osteosarcoma classification and development of new innovative adapted therapies in children, adolescent and young adults.

Chirurgie ORL - Contact

Contact

ORL

01 42 11 56 88

Chirurgie reconstructrice

01 42 11 65 36

Oncologie

01 42 11 46 05

Pediatric Cancer Researchers Receive $1.3 Million to Study Precise Treatment for Neuroblastoma

November 16, 2020

Pediatric Cancer Researchers Receive $1.3 Million to Study Precise Treatment for Neuroblastoma

Grant awarded to CHOP and Gustave Roussy to support phase 3 clinical trial developed by Children’s Oncology Group and International Society of Paediatric Oncology Europe Neuroblastoma Group, representing first-ever collaboration between North American and European neuroblastoma consortia

Pages